Prevalence of hepatitis C in the adult Mexican population: National Survey of Health and Nutrition 2018

Carnalla, Martha; Barrientos‐Gutiérrez, Tonatiuh; Vidaña-Pérez, Dèsirée; Romero-Martínez, Martín; Martínez-Bohorquez, María Carolina; González-Pier, Eduardo; Fagundo-Sierra, Reynerio; Alpuche-Aranda, Celia; Lazcano‐Ponce, Eduardo; Shamah‐Levy, Teresa

doi:10.1016/j.lana.2021.100165

Cited by 2 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the prevalence of HBV and HCV continues to be higher if we compare it with the national prevalence in general population. Rojo-Medina J. et al showed that the prevalence in general population of HBV in the years 2000 to 2012 within blood donors was 0.47% to 0.15%, while Carnalla M. et al showed that for HCV the national prevalence was 0.23% in the year 2018 [ 21 , 22 ]. Furthermore, a pooled epidemiological report performed by the Pan-American Health Organization mentions that within Latin-American population, HBV yields a prevalence of 0.33% and HCV of 0.73%, respectively [ 23 ].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Prevalent coinfection and associated factors for Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus in patients submitted to renal replacement therapy: A cross-sectional study of 21 dialysis units in the State of Mexico

Palomo‐Piñón

Antonio-Villa²,

García‐Cortés

et al. 2022

PLoS ONE

View full text Add to dashboard Cite

Background Chronic kidney disease (CKD) predispose to viral coinfections in patients submitted to renal replacement therapy (RRT); nevertheless, few reports have been performed to elucidate the current epidemiology within this population in Mexico. Aim To estimate the prevalence of HBV, HCV, and HIV coinfection and to explore factors associated with prevalent coinfection in patients living with renal failure undergoing to RRT. Methods A multicenter cross-sectional recruitment across 21 units at the Mexican Institute of Social Security (IMSS) at the State of Mexico was performed during 2019. A standardized clinical questionnaire was performed to elucidate individual and relatives-related conditions. A treatment facility questionnaire was applied to the chief responsible of each unit to explore treatment facility variables. Serological testing, clinical, biochemical, and anthropometrical parameters were extracted from clinical records. Result In 1,304 patients (57.5% male, mean age 45.5 (SD: 15.6) years, and 95.8% in hemodialysis), the prevalence of any viral coinfection was 3.14% (95% CI: 2.32%-4.23%). The highest viral coinfection prevalence were for HCV, HBV, and HIV, in which men and subjects diagnosed after 2010’s had the highest rates. We identify that being submitted to peritoneal dialysis, being treated in a surrogated dialysis center and living with a close relative with prior hepatitis coinfection were associated factors for any viral coinfection. Conclusion In patients submitted to RRT, the prevalence of viral coinfection remains high compared with general population. Screening strategies, medical awareness and targeted public healthcare policies should prioritize better care practices within patients submitted to RRT in Mexico.

show abstract

Section: Discussionmentioning

confidence: 99%

“…2018 [21,22]. Furthermore, a pooled epidemiological report performed by the Pan-American Health Organization mentions that within Latin-American population, HBV yields a prevalence of 0.33% and HCV of 0.73%, respectively [23].…”

Section: Plos Onementioning

confidence: 99%

Prevalent coinfection and associated factors for Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus in patients submitted to renal replacement therapy: A cross-sectional study of 21 dialysis units in the State of Mexico

Palomo‐Piñón

Antonio-Villa²,

García‐Cortés

et al. 2022

PLoS ONE

View full text Add to dashboard Cite

show abstract

“…[2] In Mexico, HBV and HCV seroprevalence is low and the proportion of the population reporting excessive alcohol consumption is moderate. [3][4][5] Recently, AFB1 exposure was shown to be highly prevalent (>90% detection) at moderate levels of exposure [6]. Finally, in Latin America, there has been an increase in HCC cases related to metabolic dysfunction-associated fatty liver disease (MAFLD).…”

Section: Introductionmentioning

confidence: 99%

Characteristics of Hepatocellular Carcinoma by Sex in Mexico: A Multi-institutional Collaboration

Melchor-Ruan,

Santiago Ruiz,

Murillo-Ortiz

et al. 2024

Preprint

View full text Add to dashboard Cite

Liver cancer is the fourth leading cause of cancer-related death worldwide. In Mexico, there is a high burden of liver cancer mortality in rural states, which affects both women and men equally. Thus, we aimed to describe the demographic and clinical characteristics of hepatocellular cancer (HCC) by sex in Mexico. Demographic and clinical information were extracted retrospectively from the medical records of patients with HCC initially treated (2015-2022) at participating institutions of a national survey across the country. The male-to-female ratio was calculated at the national and regional levels and the results were stratified by sex. Among 697 HCC patients, the age at diagnosis was 65.4±11.9y and 20% were diagnosed at ≥75y. The male-to-female ratio was 1.4:1, ranging from 1:1 in the northwestern and southwestern regions to 2.1:1 in the western region. The proportion of cirrhosis was similar between sexes; however, the etiologies for cirrhosis differed: cryptogenic cirrhosis was higher in women and alcohol consumption was higher in men. Men had a higher proportion of advanced HCC, poor/undifferentiated tumors, and ≥4 nodules than women. HCC in the Mexican population affects men and women at a 1.4:1 male-to-female ratio. This unique proportion by sex could be explained by the differences in the prevalence of risk factors across our heterogeneous country.

show abstract

Prevalence of hepatitis C in the adult Mexican population: National Survey of Health and Nutrition 2018

Cited by 2 publications

References 13 publications

Prevalent coinfection and associated factors for Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus in patients submitted to renal replacement therapy: A cross-sectional study of 21 dialysis units in the State of Mexico

Prevalent coinfection and associated factors for Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus in patients submitted to renal replacement therapy: A cross-sectional study of 21 dialysis units in the State of Mexico

Characteristics of Hepatocellular Carcinoma by Sex in Mexico: A Multi-institutional Collaboration

Contact Info

Product

Resources

About